Finally, we revealed that canthin-6-one inhibits tumour-associated angiogenesis in a zebrafish B16F10 melanoma cell xenograft model and synergises with VEGFR inhibitor sunitinib malate (SM), highlighting its potential utility as a novel anti-angiogenic drug for human cancer. The gene discussed is KDR; the disease is melanoma.